Podcasts about Pi

Share on
Share on Facebook
Share on Twitter
Share on Reddit
Share on LinkedIn
Copy link to clipboard

Ratio of the circumference of a circle to its diameter

  • 5,782PODCASTS
  • 13,467EPISODES
  • 42mAVG DURATION
  • 3DAILY NEW EPISODES
  • Jul 6, 2022LATEST
Pi

POPULARITY

20122013201420152016201720182019202020212022



    Best podcasts about Pi

    Show all podcasts related to pi

    Latest podcast episodes about Pi

    Crawlspace: True Crime & Mysteries
    295 // The Mystery of Amelia Earhart & Fred Noonan

    Crawlspace: True Crime & Mysteries

    Play Episode Listen Later Jul 6, 2022 61:25


    Welcome to Crawlspace. In this episode Tim Pilleri and Lance Reenstierna speak with author Chris Williamson about Amelia Earhart and Fred Noonan's disappearances. Get Chris's book: https://www.intotherabbithole.net/book-store/p/rabbit-hole-the-vanishing-of-amelia-earhart-fred-noonan-soft-cover-edition Amazon link: https://www.amazon.com/Rabbit-Hole-Vanishing-Amelia-Earhart/dp/B0B3SDS8R1 Follow Chris on Twitter: https://twitter.com/CWilliamson____ Vanished's site: https://www.vanishedshow.com/ Apple: https://podcasts.apple.com/us/podcast/vanished/id1441890398 Spotify: https://open.spotify.com/show/6IElGgdwTQJIaXNUyG0xsS Me & My Friends: https://podcasts.apple.com/us/podcast/me-and-my-friends/id1497998893 Spotify: https://open.spotify.com/show/2FvLPAKV4gFiPJORCMR95N Chasing Earhart: https://podcasts.apple.com/us/podcast/chasing-earhart/id1246839077 Come see us on tour with Patrick Hinds and Maggie Freleng! https://www.truecrimeobsessed.com/see-us-live Check out our Crawlspace subscription service where we have a bonus show and ad-free episodes! https://crawlspace.supportingcast.fm/ Check out our Missing subscription service where we have a bonus show and ad-free episodes! https://missing.supportingcast.fm/ Follow us on Twitter: https://twitter.com/crawlspacepod  Follow us on Facebook: https://www.facebook.com/Crawlspacepodcast  Follow us on Instagram: https://www.Instagram.com/Crawlspacepodcast Follow us on TikTok: https://www.tiktok.com/@crawlspacepodcast The music for Crawlspace was produced by David Flajnik. Listen to his music here: https://www.pond5.com/artist/bigdsound  Check out our entire network at http://crawlspace-media.com/ Join the Crawlspace Discussion Facebook group: https://www.facebook.com/groups/talkcrawlspace/ Crawlspace Media is part of the Glassbox Media Network. Check them out here: https://glassboxmedia.com/ Go to https://smile.amazon.com/ to connect your existing Amazon account to donate to PI's For the Missing. Follow Private Investigations For the Missing https://investigationsforthemissing.org/ http://piftm.org/donate https://twitter.com/PIFortheMissing https://www.facebook.com/PIFortheMissing/ https://www.instagram.com/investigationsforthemissing/ Learn more about your ad choices. Visit megaphone.fm/adchoices

    LawNext
    Ep 168: Joshua Schwadron On Pivoting His Legal Tech Company to A Law Firm to Compete with His Former Customers

    LawNext

    Play Episode Listen Later Jul 5, 2022 48:00


    It was a mighty bold move for the legal technology company Mighty. After seven years in business serving personal injury lawyers, the company recently pivoted to launch Mighty Law, a law firm that directly competes against those PI firms by offering lower fees, greater transparency, and tech-driven efficiencies.  For founder and CEO Joshua Schwadron, the move was motivated by what he sees as the misaligned incentives of PI lawyers. Rather than pass along to their clients the savings that they realize from using technology, he believes, the fee and cost structure for PI firms incentivizes them to inflate settlements and drive up costs.  Seeking to provide PI plaintiffs with lower fees and greater transparency, Schwadron, who is also a lawyer, has converted his tech company into a dual-entity structure. The law firm, Mighty Law, will represent the clients, while a separate tech and services company, Mighty, will support the law firm's operations and also provide services and support to clients to assist them in what Schwadron calls their post-accident journey. On this week's LawNext, Schwadron joins host Bob Ambrogi to talk about why he made this pivot and what he believes it means for consumers and the PI industry.    Thank You To Our Sponsors This episode of LawNext is generously made possible by our sponsors. We appreciate their support and hope you will check them out.  Paradigm, home to the practice management platforms PracticePanther, Bill4Time, and MerusCase, and e-payments platform Headnote. If you enjoy listening to LawNext, please leave us a review wherever you listen to podcasts.

    The Movie Lovers
    Episode 136: Elvis, Unreliable Narrators

    The Movie Lovers

    Play Episode Listen Later Jul 5, 2022 95:10


    In this episode of the podcast, Jeff and Shanna discuss a couple of TV shows before reviewing Baz Luhrmann's latest film, Elvis. They also count down their favorite unreliable narrator movies. You'll hear discussions about Euphoria, This Is Us, and more. Check out Jeff's latest James Bond article. https://www.thegibsonreview.com/blog/james-bond-a-review-the-dalton-and-brosnan-movies Next time on The Movie Lovers: Thor: Love & Thunder and Film Faves: Romantic Comedies. Look for it on Tuesday, 7/19. Show Notes • Opening and Introduction • The Week in Review: (0:0:58) o Shanna's Week:  Euphoria  Reacher  NYPD Blue o Jeff's Week: (0:14:27)  James Bond  This Is Us • The Main Event: Elvis (0:24:11) o The Good o The Bad • Film Faves: Unreliable Narrator Movies (1:04:43) • Where You Can Find Us and Ending (1:31:45) Our Fave Unreliable Narrator Movies: 12. Blade Runner (1982) 11. A Beautiful Mind (2001) – Hulu 10. Shutter Island (2010) 9. Rashomon (1950) – HBO Max 8. Atonement (2007) – HBO Max 7. Memento (2000) - HBO Max 6. The Usual Suspects (1995) – Prime 5. Life of Pi (2012) – HBO Max 4. The Sixth Sense (1999) 3. Gone Girl (2014) 2. Black Swan (2010) – Hulu, Prime 1. I, Tonya (2017) – Hulu

    Puedes Hacerlo
    178. Mi Meta y las Vacaciones

    Puedes Hacerlo

    Play Episode Listen Later Jul 4, 2022 14:40


    Muchas de nosotras esta época del año, solemos tomar vacaciones, si viajamos o no, el cambio de rutina de los hijos nos da esa sensación de estar de vacaciones. Sé que esto para muchas mujeres ha significado: época de descontrol en el comer, quizá  hasta descuido personal, dejar nuestra rutina de ejercicio a un lado, y sobre todo, para muchas mujeres esta época representa, época en la que seguro subiré de peso.  Y como bien puedes imaginarte, en este episodio, quiero contarte que si esta ha sido tu historia en las vacaciones, esto no tienes que seguir siendo así, si no es lo que quieres.  Esto de comer sin control, descuidar nuestro cuidado personal, dejar de hacer ejercicio, lo hacemos realidad si nos quedamos con la idea de que esta es mi única posibilidad en esta época del año. La realidad es que está en ti decidir los resultados que quieres lograr en tus vacaciones y en tu vida. Si estás en este camino hacia el logro de tu peso ideal y en el fondo del corazón estás convencida de que no tienes más opción mas que ponerle pausa a tu camino. Pausa antes de poner esa pausa.  Y cuestiónate: ¿Cómo puedes hacer que las vacaciones lejos de desconectarte con tu meta, te conecten más con ella?  Piénsalo. Si para ti las vacaciones han significado siempre descontrol, excesos, desorden y descuido, ponle a tus vacaciones un significado diferente, algo que te beneficie. Vacaciona con propósito.  Porque si tu quieres, en realidad este cambio de actividad puede ser la perfecta oportunidad para comprobar que no tienes que seguir al pie de la letra  una dieta matada para bajar de peso, todo lo contrario. Puedes comprobar cómo es que haciendo contigo simples pactos, específicos y puntuales con propósito puedes, no solo seguir avanzando hacia tu meta si tu quieres, sino puedes disfrutar más plenamente tus vacaciones y tu vida. A continuación,  tips muy puntuales que compartí junto con mi hija Fátima aquí en el podcast, justo hace un año, antes ida salir de vacaciones. Toma nota de estos tips, hazlos vida, verás que te ayudarán a seguir avanzando hacia el logro de tu meta en vacaciones.   Y aclaro, no es que todo mundo tiene que querer bajar de peso en las vacaciones. Si tu quieres hacerlo, puedes hacerlo, y además puedes disfrutarlo. Te sugiero que si quieres ponerte un único requisito en este camino, que este sea: el de disfrutar tu camino. Si no lo disfrutas, si lo sientes como obligación, déjalo a un lado. Recuérdalo, no tienes que hacerlo.  Comparto por aquí los tips deseando que disfrutes tu camino y tus vacaciones.  Tip #1. Cuestiónate qué es lo que piensas de tu proceso de bajar de peso.  Si pensamos que es un proceso horrible y sacrificado, date cuenta que precisamente por esas ideas, hacemos que sea totalmente  incompatible con el tema de las vacaciones. Háblate con la verdad.  Tip #2. Haz tus propias propuestas que lo hagan fácil y disfrutable.  Hazte tu misma propuestas que te permitan disfrutar tu proceso, que te lo hagan fácil. Toma acuerdos simples contigo misma, que hagan que elegir salud y alcanzar tu sueño sea algo que realmente disfrutas. Por ejemplo: Que tu misma te propongas tomar más agua. Regalarte pausas para elegir tus alimentos que te hacen bien y eso mismo sea lo que te permita disfrutarlos. Proponerte probar más verduras y disfrutarlas. Practicar masticar más los alimentos para disfrutarlos mas y conectar con tu nivel de saciedad.  Estar más consciente y parar de comer cuando estes satisfecha. Hacer un diario, darte tiempo para escribir sobre cómo te sientes, escribir lo que hay alrededor de tu sueno, de tus sueños. Reflexionar en el por qué  se te puede hacer difícil o porque puedes haber considerado abandonarla tu sueño o ponerle pausa. Las vacaciones pueden ser una super oportunidad para conectar con nosotras mismas.  Tip #3. Ten una “cómplice de sueño” (accountability partner)  Alguien con quien puedas compartir lo que quieras lograr y en quien puedas apoyarte. Alguien a quien puedas contarle cómo te estas sintiendo, cuáles están siendo tus obstáculos y cuáles tus estrategias. Alguien que pueda ser tu porrista. Ojo, no policía. Tip #4. Ten a la mano pensamientos que te sirven. Busca tener pensamientos a la mano que te ayuden a recordar que quieres disfrutar el proceso , que lograr tu peso ideal es algo que nadie te esta obligando a lograr y que abandonarlo no va a hacer que sea mas fácil lograrlo. Tip # 5. Disfruta Disfruta tus vacaciones super orgullosa de saber que además crees en tu sueño. Que esto sea un requisito en tu camino siempre, disfruta el hoy. Trae tu sueño contigo en la maleta, tráelo contigo y familiarízate con el hasta hacerlo realidad.  PUEDES HACERLO PD. En mi instagram estaré compartiendo más tips que te ayudarán a seguir conectada con tu meta y  algo de mis vacaciones,  sígueme aquí >> @monicasosacoach

    Mostly BS with RoyDL3
    #56 • Giveaways!!! RoyDL3 & RiceCrackerOG drop the latest info, while celebrating the freedom of USA

    Mostly BS with RoyDL3

    Play Episode Listen Later Jul 4, 2022 137:39


    ••JOIN DISCORD ➡️ https://discord.gg/ESwduvMU •• In this episode we talk about affiliate marketing and giveaways we plan to do in the future as well as content that is due to come out in the near future. Thank you for listening please visit our affiliates using the links below.⬇️ ps here is the links for the Underwater Zoo NFT Project. https://linktr.ee/underwaterzoo?utm_source=linktree_profile_share<sid=1453f559-81c8-4421-abab-6e6c2443d8f4 •Ledger Crypto Currency Hardware Wallet https://shop.ledger.com?r=e258698df4f1 •Shield Folio Crypto Passwords Private Keys Book. 10%-Off with this link https://shieldfolio.com/?ref=c12lmkxtkyif •CryptoCloaks CryptoCloaks.com 3D printed crypto tools/merch 5%-Off with Promo Code: RoyDL3 Earn FREE CRYPTO (XYO) with the Coin App 1000 free Coins with this link https://coin.onelink.me/ePJg/x7h3f0z7 Pi is a new digital currency developed by Stanford PhDs, with over 33 million members worldwide. To claim your Pi, follow this link https://minepi.com/roydl3 and use my username (roydl3) as your invitation code. Earn Bitcoin for walking and Bitcoin back on purchases!!! https://join.smilesbitcoin.com/RoyDL3303 Earn and win free NFTS and redeem BNB with: NinjaFT https://ninjaftapp.page.link/2ab1 Contact us: RoyDL3 Twitter: @CoinBoyRoyDL3 Instagram: @roydl3 Truth Social: @RoyDL3 A HellaPro Production --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/roydl3/message Support this podcast: https://anchor.fm/roydl3/support

    Is That Even Legal?
    Personal Injury Lawyers...They are NOT All the Same!

    Is That Even Legal?

    Play Episode Listen Later Jul 4, 2022 35:53


    The ads are ubiquitous. The slogans annoying. Personal injury and car crash lawyers often get a bad rap. Sometimes deservedly so. As widespread as those billboards, radio ads and other assaults on the senses are...they are meant to address something almost all of us has experienced, or been touched by - a car accident.  When those accidents produce injuries, the "PI" lawyer is suddenly needed.  How do you find a good one?  Does a bad ad make for a bad lawyer? Does no ad make for a good lawyer?  Let's find out as Bob interviews Kevin Fine, a PI lawyer and a wellness advocate.As you listen, mull these stats over from drivingtests.org:In 2019, there were 6,756,000 police-reported motor vehicle crashes, including 1,916,000 crashes involving injury and 33,244 crashes involving death. (NHTSA, 2021) In 2010, the economic cost of traffic crashes (both reported and unreported) was estimated to be about $242 billion, plus an additional $594 billion in societal costs resulting from the effects of these crashes on the victims, for a total cost of $836 billion. This total cost represented about 5.6% of the US Gross Domestic Product (GDP) in 2010. (NHTSA, 2017) (Source: https://driving-tests.org/driving-statistics/)Around 2 million drivers in car accidents experience permanent injuries every year. (Driver Knowledge, 2019) (Source: https://driving-tests.org/driving-statistics/)About 10 million or more crashes go unreported each year. (National Highway Traffic Safety Administration, 2018) (Source: https://driving-tests.org/driving-statistics/)

    Crawlspace: True Crime & Mysteries
    294 // Crypt - UAP's & The Deep End

    Crawlspace: True Crime & Mysteries

    Play Episode Listen Later Jul 3, 2022 55:47


    Welcome to Crawlspace. In this episode Tim Pilleri, Lance Reenstierna and Jennifer Amell dish on the Crawlspace Crypt! We discuss upcoming episodes, Tim discusses his UAP vacation, and Jenn discusses Teal Swan and the new documentary The Deep End. This format typically runs on our Crawlspace Premium feed. Check it out at https://crawlspace.supportingcast.fm/ News articles referenced for this episode: https://www.thesun.co.uk/news/19026198/mysterious-lights-spotted-san-diego-ufos-pacific-ocean/ https://www.nbcsandiego.com/news/local/mysterious-lights-in-san-diego-sky-were-military-flares/2982084/?_osource=db_npd_nbc_knsd_twt_shr https://www.hulu.com/series/e052aae5-14fb-4043-bb11-94f5880421b3 https://en.wikipedia.org/wiki/Teal_Swan https://decider.com/2022/05/18/the-deep-end-freeform-review/ Check out our Missing subscription service where we have a bonus show and ad-free episodes! https://missing.supportingcast.fm/ Follow us on Twitter: https://twitter.com/crawlspacepod  Follow us on Facebook: https://www.facebook.com/Crawlspacepodcast  Follow us on Instagram: https://www.Instagram.com/Crawlspacepodcast Follow us on TikTok: https://www.tiktok.com/@crawlspacepodcast The music for Crawlspace was produced by David Flajnik. Listen to his music here: https://www.pond5.com/artist/bigdsound  Check out our entire network at http://crawlspace-media.com/ Join the Crawlspace Discussion Facebook group: https://www.facebook.com/groups/talkcrawlspace/ Crawlspace Media is part of the Glassbox Media Network. Check them out here: https://glassboxmedia.com/ Go to https://smile.amazon.com/ to connect your existing Amazon account to donate to PI's For the Missing. Follow Private Investigations For the Missing https://investigationsforthemissing.org/ http://piftm.org/donate https://twitter.com/PIFortheMissing https://www.facebook.com/PIFortheMissing/ https://www.instagram.com/investigationsforthemissing/ Learn more about your ad choices. Visit megaphone.fm/adchoices

    Another MMA Podcast
    Episode 5 UFC 276 Embedded (AMP'd) | #UFC #UFC276

    Another MMA Podcast

    Play Episode Listen Later Jul 1, 2022 9:48


    The stars preview their big matchups at media day, then do it again for fans at the press conference. Pedro Munhoz readies at the PI. Alex Pereira trains with legend Glover Teixeira.

    COSMO Radio po polsku
    Niemcy z bliska: zmiany od 1 lipca

    COSMO Radio po polsku

    Play Episode Listen Later Jul 1, 2022 6:08


    Piątek, 1 lipca: rząd zatwierdza projekt budżetu na 2023 rok, komisja ekspertów wyciaga wnioski z obostrzeń wprowadzonych podczas pandemii, powiemy również o zmianach w przepisach od 1 lipca oraz zajrzymy do niemieckiej prasy. Zaprasza Monika Sędzierska Von Monika Sedzierska.

    Girl Talk with Amy & Ashlee
    Talking - Personal Investigator Tool 075

    Girl Talk with Amy & Ashlee

    Play Episode Listen Later Jul 1, 2022 16:10


    Hey Girlfriends, What do you do when you feel BIG emotions?? We talked on a previous episode that emotions are not bad. They are like the check engine light on the dashboard of a car. Notice the emotions and take a minute to analyze why you are having that emotion. We are sharing today the questions we use to understand the thinking behind our emotions. We call it the PI tool (personal investigator tool) When we get to the root of what is causing the emotion we can live a peaceful and free life! #GirlTalk #podcast #emotions

    Personal Injury Marketing Mastermind
    129. Robert Ingalls, LawPods — Podcasting for Attorneys: A Crash Course

    Personal Injury Marketing Mastermind

    Play Episode Listen Later Jun 30, 2022 48:46


    Podcasting has the power to build communities, share your authentic voice and unlock marketing potential. Today's episode is for every attorney who has thought, "I really should start a podcast" but isn't sure how. Robert Ingalls, Chief Podcast Strategist at LawPods, shares with us his passion in hopes that it will help you improve your business and connect with your audience. We discuss how to get the most out of branded content, podcasting best practices, and how extreme ownership can really take your firm to the next level. What's in This Episode Who is Robert Ingalls? Why did he leave a career in law to start a podcasting agency? Why should every attorney consider podcasting? What common mistakes should attorneys considering a podcast avoid? How can attorneys repurpose podcasts for short-form social media? What is the best podcast format for PI attorneys and who should they be interviewing? How do you create an engaging podcast? How to get amazing audio quality without having to go to a studio? How do you navigate a less than perfect interview?

    Creeps & Crimes
    S2: MISSING: Andrea Knabel

    Creeps & Crimes

    Play Episode Listen Later Jun 30, 2022 59:31


    PART 2 OF EPISODE 92 Andrea Knabel was 37 years old when she went missing on August 13, 2019 in Audubon Park, Louisville, Kentucky. Andrea worked as a PI for a group called Missing in America searching for people's missing loved ones- and now it is our turn to fight for her. Andrea is one of us. She fought to bring missing people home, advocating for families, working in private investigating. She's a mother, a sister, a daughter, a friend, and so much more. If you know anything about Andrea's disappearance or current whereabouts please contact 502-574-7120 or 502-618-9337 To help in the investigation or spread awareness about Andrea's case please follow Erin Knabel or Finding Andrea/Where is Andrea Knabel on all Social Media Platforms  We want to thank Erin and Mike Knabel for trusting us to cover Andrea's case and share it with you all. Erin and Mike have been extremely kind, responsive, and open with us about some of the darkest days in their life. Andrea Knabel is now 40 years old, she is 5'7, 190lbs, with brown natural hair and blonde highlights. Her eyes are hazel green, with no tattoos. Sources: Erin & Mike Knabel, Dr. Phil, Armchair Detective, Investigation Discovery 4 Part Series, WHAS11 “We Don't Feel Let Down, We Are Let Down” Article written by McAlister and Weiter April 16, 2021, ID Crimefeed “Woman Who Helped Find Missing People Disappears” Dec. 29, 2021 by Aaron Rasmussen, Daily Mail UK “Single Mother of two Missing” Aug. 29, 2019 by Farberov, Reddit, Narratively: Mark Oprea- The Missing Persons Investigator who Went missing herself, (more to be added)

    Another MMA Podcast
    Episode 3 UFC 276 Embedded (AMP'd)| #UFC #UFC276

    Another MMA Podcast

    Play Episode Listen Later Jun 30, 2022 9:44


    Sean O'Malley wraps his camp and dyes his locks. Champion teammates Israel Adesanya and Alexander Volkanovski take over the PI, then Max Holloway gets his turn. Jared Cannonier starts his business trip. UFC 276 is on Saturday, July 2.

    Simulation
    #803 Dr. Tiannan Guo — Proteomic Big Data

    Simulation

    Play Episode Listen Later Jun 29, 2022 84:40


    Dr. Tiannan Guo is a PI at Westlake University and Founder of Westlake Omics boosting precision medicine and drug research and development by integrating technological innovations in proteomics and multimodal big data. https://guomics.com https://westlakeomics.com/en https://twitter.com/guomics https://twitter.com/OmicsWestlake What is I? ► https://bit.ly/WhatisI High Level Perception ► https://highlevelperception.com No Limits Society ► https://bentinhomassaro.com/nls

    Wild Business Growth Podcast
    #197: Jessica Leigh Clark-Bojin – Pie Artist, Pies Are Awesome

    Wild Business Growth Podcast

    Play Episode Listen Later Jun 29, 2022 48:32


    Jessica Leigh Clark-Bojin, the World-Renowned Pie Artist, joins the show to share her journey from fencing and filmmaking to baking the most creative pies on Earth. Hear how to do what you love full-time, Jessica's creative pie process, the science of pies, restaurant menu she can recite in its entirety, and how many digits of Pi she knows. Connect with Jessica at PiesAreAwesome.com

    Montreux Comedy Edition Audio
    Yellow Mic #11 - Ahmed Sparrow

    Montreux Comedy Edition Audio

    Play Episode Listen Later Jun 29, 2022 36:04


    Toutes les deux semaines, découvrez un nouvel épisode de Yellow Mic, le podcast qui retrace l'histoire derrière une bonne vanne et comment elle a évolué pour arriver jusqu'en Suisse, sur la scène du Montreux Comedy Festival.Ahmed Sparrow aime décortiquer les éléments basiques de la vie quotidienne pour en faire des blagues. Comment analyse-t-il les réactions du public ? Comment teste-t-il ses blagues dans les Comedy Club ? Pourquoi fait-il passer des sentiments contradictoires sur scène ? Autant de questions dont vous trouverez les réponses et éléments de réflexion dans ce podcast.Dans ce onzième épisode, l'humoriste retrace les débuts de sa carrière, et revient sur ses précédents passages au Montreux Comedy Festival avec les sketchs “Le tennis” et “Piétons vs Automobilistes”. Il se confie notamment sur l'écriture de ses sketchs, les secrets de ses phrases d'accroche et de ses transitions mémorables.N'hésitez pas à réagir et à donner votre avis sur les réseaux sociaux. #MontreuxComedy #YellowMicSuivez toutes nos actualités sur YouTube, Instagram, Facebook, Twitter, TikTok et sur notre site web. Voir Acast.com/privacy pour les informations sur la vie privée et l'opt-out.

    Effetto giorno le notizie in 60 minuti

    Svezia e Finlandia nella Nato, il vertice di Madrid dell'Alleanza segna la svolta storica. Biden annuncia: "Più truppe in Occidente". Ne parliamo con Matteo Villa, analista dell'ISPI.Diciannove città col bollino rosso per il caldo oggi al centro sud, da Bologna a Catania, allerta piogge invece al nord. Con noi Giulio Betti del CNR.

    Reading Through Life
    45: What Exactly Is Magical Realism?

    Reading Through Life

    Play Episode Listen Later Jun 29, 2022 27:36


    Show notes: Ahhh, magical realism. It's a genre that Sarah and Mia both love because it's like real life, with a little bit of spice. In this episode, we'll talk about what magical realism is, how it differs from fantasy books, what we love about this genre, and of course, we'll include some book recommendations. It's just how we do it, folks.    Click here to join us on Patreon to get an exclusive bookish goodie every single Friday. With fun bonus episode series like: Books We Both Love, Monthly Overflow Books, Bookish Conundrums, and The New Books in Our Lives plus a private community for RTL Book Nerds only, you're going to love being a part of our Patreon. Not only that, but you're helping to support our show by saying I LOVE WHAT YOU DO.    Find the time stamped show notes below with links to all of the fun things we mentioned.   Bookish Goodies: [3:50] Sarah - Storygraph [5:10] Mia - Hidden Pictures by Jason Rekulak   Magical Realism Reads: [10:08] Mia - Life of Pi by Yann Martel [11:02] Sarah - The Invisible Life of Addie LaRue by V.E. Schwab [12:09] Mia - The Night Circus by Erin Morgenstern [13:58] Sarah - The Midnight Library by Matt Haig [15:38] Mia - Chocolat by Joanne Harris [17:11] Sarah - The Cat Who Saved Books by Sōsuke Natsukawa [19:07] Mia - Ninth House by Leigh Bardugo [20:39] Sarah - In a Holidaze by Christina Lauren [21:55] Mia - The Magic Strings of Frankie Presto by Mitch Albom [24:01] Sarah - The Lost Apothecary by Sarah Penner   [25:30] Sarah's Bonus Recs: One Italian Summer by Rebecca Serle Under the Whispering Door by TJ Klune The House in the Cerulean Sea by TJ Klune Amari and the Night Brothers by BB Alston Landline by Rainbow Rowell One Last Stop by Casey McQuiston Practical Magic series by Alice Hoffman   [26:16] Sarah's Magical Realism TBR list: This Time Tomorrow by Emma Straub A History of Wild Places by Shea Ernshaw Hotel Magnifique by Emily J. Taylor The 7 ½ Deaths of Evelyn Hardcastle by Stuart Turton   Follow us on Instagram: @readingthroughlifepod Follow Sarah: @thekindredvoice Follow Mia: @miasutton55   * The books noted above contain affiliate links. This means that we may get a small kickback if you purchase through our links, at no additional cost to you.

    Crawlspace: True Crime & Mysteries
    293 // Weirdspace - Part 2

    Crawlspace: True Crime & Mysteries

    Play Episode Listen Later Jun 29, 2022 38:29


    Welcome to Crawlspace. In this episode Tim Pilleri and Lance Reenstierna dig into some weird stories that have been haunting the Crawlspace idea board. Topics range from the globally feared Monk of Pontefract, to a heart-warming story about a cat who was reunited with its owner after 4 years of being lost. News articles referenced for this episode: https://www.ladbible.com/news/ghost-hunter-tricks-black-monk-pontefract-photo-tears-20220609 https://www.hauntedrooms.co.uk/30-east-drive-pontefract-poltergeist-house https://www.upi.com/Odd_News/2022/06/08/lost-cat-found-four-years-New-Hampshire/1041654720359/ The Hands Resist Him EF Link: https://podcasts.apple.com/us/podcast/bonus-the-hands-resist-him/id1339744456?i=1000464902109 Bill Stoneham: https://www.stonehamstudios.com/haunted Check out our Missing subscription service where we have a bonus show and ad-free episodes! https://missing.supportingcast.fm/ Follow us on Twitter: https://twitter.com/crawlspacepod  Follow us on Facebook: https://www.facebook.com/Crawlspacepodcast  Follow us on Instagram: https://www.Instagram.com/Crawlspacepodcast Follow us on TikTok: https://www.tiktok.com/@crawlspacepodcast The music for Crawlspace was produced by David Flajnik. Listen to his music here: https://www.pond5.com/artist/bigdsound  Check out our entire network at http://crawlspace-media.com/ Join the Crawlspace Discussion Facebook group: https://www.facebook.com/groups/talkcrawlspace/ Crawlspace Media is part of the Glassbox Media Network. Check them out here: https://glassboxmedia.com/ Go to https://smile.amazon.com/ to connect your existing Amazon account to donate to PI's For the Missing. Follow Private Investigations For the Missing https://investigationsforthemissing.org/ http://piftm.org/donate https://twitter.com/PIFortheMissing https://www.facebook.com/PIFortheMissing/ https://www.instagram.com/investigationsforthemissing/ Learn more about your ad choices. Visit megaphone.fm/adchoices

    Another MMA Podcast
    Episode 2 UFC 276 Embedded(AMP'd)| #UFC #UFC276

    Another MMA Podcast

    Play Episode Listen Later Jun 28, 2022 8:07


    Max Holloway does a sit down at T-Mobile and a shakeout at the PI. Champs Alex Volkanovski and Israel Adesanya cheer on a teammate in the Octagon. The Kiwis push hard in the gym. UFC 276 is on Saturday, July 2. #UFC #UFC276

    My Favorite Detective Stories
    Edith Maxwell | My Favorite Detective Stories Episode 167

    My Favorite Detective Stories

    Play Episode Listen Later Jun 28, 2022 48:01


    Edith was first recognized for her fiction writing at the age of eleven. She won the Pasadena Star News contest for her short story, “Viking Girl” and walked away with the prize money of $2.00!In 2013 she left high-tech to write mystery fiction full-time and is now living her dream. Edith is a lifetime member of Sisters in Crime, and is a member of Mystery Writers of America. She is also a long-time member of the Society of Friends (Quaker) and a past Clerk of Amesbury Friends Meeting. Her art story was featured in the National Endowment for the Arts 50th anniversary celebration. Edith blogs with five other New England mystery authors at WickedAuthors.com who were featured in the Boston Globe.She also blogs at Mystery Lovers' Kitchen on the second and fourth Fridays of the month.https://edithmaxwell.com/Today's episode is brought to you by John's full series of crime thrillers available right now. You can get them through Amazon here: https://www.amazon.com/John-A.-Hoda/e/B00BGPXBMM%3Fref=dbs_a_mng_rwt_scns_share  You can also sign up for the newsletter at http://www.JohnHoda.com to get a free copy of John's new novella Liberty City Nights.Thank you for listening. If you have a moment to spare please leave a rating or comment on Apple Podcasts as that will help us expand the circle around our campfire. If you have any questions please feel to reach out to me via my website http://www.johnhoda.com

    Circulation on the Run
    Circulation on the Run: Come Meet the CardioNerds™

    Circulation on the Run

    Play Episode Listen Later Jun 28, 2022 24:12


    This week's special podcast features the CardioNerds. Join Maryjane Farr, Vanessa Blumer, and M. Trejeeve (Tre) Martyn as they interview Amit Goyal and Daniel Ambinder, who started the Cardio Nerds podcast, website, and learning resources. Dr. Maryjane Farr: Welcome, everybody, to Circulation on the Run. My name is Maryjane Farr from UT Southwestern, and here we have an opportunity to take a week from Circulation on the Run and let our social media editors take over and do an interview of their choice. To welcome both two of our social media editors, first, Vanessa Blumer, who is going to be doing her postgraduate year seven in Cleveland Clinic, in advanced heart failure, and Trey Martin, who is a newly-minted faculty member in heart failure and amyloidosis and population health at the Cleveland Clinic. And they've chosen to interview Dan Ambinder and Amit Goyal of CardioNerds. Dr. M. Trejeeve (Tre) Martyn: So, thanks to Vanessa and to Dr. Farr for setting this up, and thanks for Amit and Dan for being here. Really excited to talk to you guys. The first thing I want to start off with is to get a little bit of an origin story about CardioNerds. And if you could tell us how you got started and how this all came to be, I think the listeners would be interested to hear that. Dr. Daniel Ambinder: Thank you so much, Trey, and it is really great to be here and nice to meet you. This is Dan. So, the origins of CardioNerds actually began early 2019. One of our mentors put us together, Dr. Reza Manesh, who's one of the co-founders of Clinical Problem Solvers, and thought that we should be thinking about potentially starting a podcast. And that definitely lit the spark and is it going to be something that's worthwhile pursuing? Dr. Daniel Ambinder: And so, we said to ourselves, at rounds we could teach five people at Noon conference, maybe we could reach out to 20 and to 40 people, but maybe with a podcast, we could reach 500 people at a time and that would be something that would be really worthwhile. So let's just sit down, create a script and start from there. And we created the first episode, aortic stenosis, and we did the recording and we just loved that process. And after that, we said, "This is worth it." So we made a couple more episodes- Dr. Amit Goyal: Hey, I'm just going to chime in here real quick. This is Amit. And I'll start off by saying, thank you so much for this invitation and what a joy it is to be doing this with two people who we respect so much, Vanessa and Trey. The process of creating this podcast and education, we learned so much. And it was so much fun that we decided why don't we just give it a shot and trial it by creating maybe three, maybe four episodes and seeing how it goes from there. So that was a backstory. Dr. M. Trejeeve (Tre) Martyn: I was curious how you guys thought about initially getting traction. Because that, I think, is the really challenging part and how you thought about getting listenership for your podcast and expanding. And was it focusing on the product, obviously? But I was curious how you, because now you have, you guys have this gravitational pull of prominent faculty and trainees that want to work with you, but how did you get there, and what was the strategy in doing that? Dr. Amit Goyal: I'll say that, initially, like Dan said, that we went out with the idea of just giving it a shot, seeing if it fit with our schedules, seeing if we enjoy the process and if there was enough of a need and a desire for this. And so, we said, why don't we create a short number of episodes? And if we could get 500 listeners, that would be the biggest audience that we have individually reached. And before you knew it, the 500 per episode turned into 5,000 per episode. Dr. Amit Goyal: And we realized that, even without actively and very deliberately trying to promote this, there was already a need and a desire for this. There was a niche that we were filling that we hadn't realized. The value of asynchronous medical education for people within or people who are interested in the care of patients with cardiovascular illness. So I think that's one. I think that's one takeaway, that there is value for open access, asynchronous education that is high quality. Dr. Amit Goyal: I think from there, our next big major pivot was well into COVID-19 when ACGME and the bodies decided that we should have virtual recruitment. This is when, enter Dr. Nosheen Reza, who was the chair of ACC FIT section at the time. And she messaged us on Twitter early afternoon, one day, saying, hey, is there maybe a way we could potentially use social media and the growth that cardio nurses has already had up until that point to maybe help connect residents with programs, ACGME accredited cardiology program, to have their fellows present a case, use one of their experts to provide an editorial expert commentary and then had the program director have a message for the applicants. Dr. Amit Goyal: And in discussing the case, the fellows would also talk about the program. And what that did was, I think, internally for us, it helps us realize that this just made it so much, the quality of the content and the breadth of the content, the depth of content just skyrocketed, right? I mean, we had fellows bring us cases of preeclampsia and bicuspid aortic valve, aortic stenosis with pregnancy. I mean, it was just, it was incredible that CardioNerds wasn't just about what we wanted, it was very rapidly turning into a communal entity that other people could take pride of. And so, that became really important to us. Dr. Daniel Ambinder: Yes. And I'll just add, again, as Amit's explained is, it happened sequentially. But it was actually a pivotal moment, right before the CardioNerds case report series was launched, where things were feeling stale. We definitely love to teach, there's no doubt about it, and that is a huge part of this. But there was a certain point where we were teaching and we just felt like there needs to be something more. Dr. Vanessa Blumer: Thank you so much, Dan and Amit. I mean, I think everything that you do, this is Vanessa. I think everything that you guys do, it's so inspiring for, I think, all generations, right? I think it's inspiring for future generations, but I think you guys inspire people at all levels. When you think about CardioNerds, what is your purpose? What drives you? What is your motivation? What do you think is your ultimate, why? Dr. Daniel Ambinder: While we had this passion to educate, that is not necessarily the why. And all of a sudden, as soon as we took off, there was multiple opportunities and multiple things dragging us in different directions. And we immediately sought out our mentor, Dr. Sanjay Desai, who is our program director at the Osler Medical Residency, and he said, "You got to find out your why right away." So, now our why includes to create and disseminate education, promote diversity, equity, inclusion, foster wellness, and humanity in the field of cardiology and in life, and provide mentorship and sponsorship and invigorating a love of cardiovascular medicine and science. Choices were easy. We can just say, "Does this fit the rubric of our mission? Is this an opportunity that we want to pursue? Is this something that's going to enhance this mission?" Dr. Amit Goyal: Putting words to a mission was extremely helpful for us. And actually, part of that conversation we're having at that time was around diversity and inclusion, because that's when Sanjay was saying you have to define what your organization stands for and what is a mission, and who are the people that are going to represent these cardiology fellowship training programs, in the eyes of residents who are thinking about a field in cardiology, and how deliberate we want to be about asking program directors to be cognizant about representing diversity in the fellows that they have representing the programs. And so, around these discussions, that's when Sanjay said, okay, there are a lot of things that you can do with CardioNerds, but before you do that, figure out what is your goal and how every action fits into that goal. Dr. M. Trejeeve (Tre) Martyn: Thanks, Amit. So, keeping that mission that you described in mind, what do you think is the ultimate goal of CardioNerds? Or, I guess I should say, where do you see CardioNerds being in five to 10 years? I know that's far out and some of the days you're just trying to get through the day you have in front of you. But if you could envision a future and, in the structure or the mission, keeping that in mind, where do you see CardioNerds in five years, let's say? Dr. Amit Goyal: Yeah, thanks, Trey. That is such an important question and a very difficult question to answer. I will say that things have evolved so quickly. And so, I think our one challenge that we talk about that we don't know how to resolve just yet is how to build CardioNerds in a way that's scalable, that outlives us. How do we make CardioNerds go beyond us? And that's Dan and I, but also everyone else within CardioNerds, a generation later. How do you maintain CardioNerds? Dr. Amit Goyal: And I think the logistic part of that is probably not that hard to figure out, right? You need admin support, you need resources, you need to delegate, you need leadership structure, but how do you grow it and have it outlive you in a way that still continues within the ethos of how you started it, within that mission, within the goals that you set it out to? And I think that's really something that we have to figure out, but that's going to be probably a deliberate way of how we grow it and how people grow into a leadership structure within it, how we design the programs. So I think that that part of the growth depends on the actions and the decisions we make today. Dr. Daniel Ambinder: Yeah. I definitely agree with all of that. And just to be brief, I just reiterate, CardioNerds is really for the people and what people want changes. And so, we're always listening and we're getting tons of feedback. And as the network grows, people are coming to us with projects and ideas, and we always try to find people that are just really passionate about what they want to do and give them a space to do it and try to give them as many resources and mentorship and sponsorship as we can, and then get out of the way. And so, that has already been a great recipe for a lot of different outpouchings and outgrowths of CardioNerds that really, again, goes back to the entire mission. And so, it's almost really hard to predict what will happen in five to 10 years, but we are ready and listening and looking to see what we can help the community with and vice versa. Dr. Vanessa Blumer: Thank you so much, Dan. And I mean, these answers have been fascinating, honestly. This interview, in general, has just been so enlightening. Dan, I think you touched on the point of democratizing cardiovascular education, which I think is, or should be, one of the highlights of this interview. Can you maybe touch a little bit more on this? And we talked about the why, can you talk about the how and see how you see this moving forward? Dr. Daniel Ambinder: Yeah. Thanks so much, Vanessa. We agree, democratization of cardiovascular education, what does that even mean? But what we mean by that is that why should somebody, somewhere off in a distant country, not have the ability to take care of their patients in the most topnotch way, because they may not have had the exposure to a particular part of cardiovascular education? Breaking down some of the formal barriers between levels of trainees, so, for example, CardioNerds' journal club really encompasses that. Dr. Daniel Ambinder: Once a month, our CardioNerds Academy, which you haven't talked about, puts on an amazing show. It's really a way where journal club hits Twitter in a traditional format, same process of discussing the article, but in the Twitter format. So it allows for this amazing group of, usually hundreds of people, honestly, to come together and discuss. And what's so amazing is that the scientific community has really gotten on board. So we often have authors of the papers that we're discussing join the actual Twitter club. Dr. Daniel Ambinder: And then we have medical students that are asking questions of the authors and this amazing engagement between multi-levels of education coming together. There are certainly ways that some, I wouldn't say the barriers, there are certain ways that these things can be helpful, like traditional learning and formats like that, but sometimes not. And so, we aim to be constructively destructive in terms of that way. And that's what we've done with democratization of cardiovascular education. Dr. Amit Goyal: If I might just add, then when we think about democratizing cardiovascular education, it's both for the learner, in terms of making high-quality education available and accessible, but also for the educators, right? I had a conversation with a mentee when he was a resident, and he called me and said, "Amit, I want to be an interventional cardiologist, but I also want to be a medical educator. How does that work?". And the fact that he was asking that is, for me, a problem, right? Dr. Amit Goyal: I've had this conversation with Dr. Katie Berlacher, who was also a medical educator, but is a cardiologist. Why does there seem to be strain between becoming a medical educator and becoming a cardiologist, right? That's not there for hospitalist medicine and other fields. So that's part of the reason we really enjoy having all sorts of trainees and faculty come on and teach on the show and be deliberate about how they want to teach on the show. Dr. M. Trejeeve (Tre) Martyn: Thanks a lot, Amit and Dan. In some ways, it sounds like you guys have been able to democratize another area other than education, which is clinical trials. And I wanted to get your perspective and hear a little bit more about the CardioNerds Clinical Trials Network. It really seems like an amazing program you guys have set up. Dr. Amit Goyal: It all goes back to the mission, but the origins of that is, Dr. Starling, he was a pretty early adopter for CardioNerds. He was a part of our very early heart failure series back in early 2020. And he was such a great supporter and source of encouragement and mentorship for so long. And Trey, I know you understand this, and Vanessa, you too, but he, for one reason or another, he brought up CardioNerds at a meeting about PARAGLIDE-HF. And I think present were Dr. Eugene Braunwald, who's part of the steering committee and Dr. Robert Mentz, who is the lead principal investigator, began recruiting around the time of COVID-19, affecting recruitment for a lot of trials. Lot of challenge there that I think we can all understand at this point. Dr. Amit Goyal: And we said, "Okay, well, not sure. We haven't thought about clinical trials, but why don't we think about it and get back to you?" So then, we said, okay, well, what's the core strength of CardioNerds? It's the people, right? After we did the CNCI recruitment series, hosting fellowship training programs, we realized that that worked out really well, because brilliant fellows from all these different programs came and elevated the education. So we established the Healy Honor Roll, after Dr. Bernadine Healy, of training programs who are part of the honor roll by nominating a FIT ambassador, a fellow and training ambassador, who's interested in education. Dr. Amit Goyal: We said, okay, well, why don't we just extrapolate that to a clinical trial? Instead of fellowship training programs, it would be trial sites that have training programs affiliated with them. Instead of a program director nominating a FIT ambassador for education, it would be the site PI nominating a FIT trialist for recruitment. But how would that fit as part of the mission? Well, with the Healy Honor Roll, with the academy, with everything else, hosting people on the podcast, it's always been, how do we pair content creation with personal and professional development? Dr. Amit Goyal: So, with a clinical trials network, the question was, how do we pair equitable trial enrollment with FIT personal and professional development? How do we meaningfully engage the fellows in the conduct of clinical trials, but also meaningfully help develop their interest in clinical trials and academic careers? How do we equip them with important skills and knowledge in the space? So we created a curriculum that's related to career development and equitable enrollment. And then, also, how do we make sure that they have, and deliberately, they have networking and mentorship as part of this? Dr. Amit Goyal: Since then, after we got all the fellows involved, the impact has been absolutely amazing. Because there are two goals here, right? There's equitable recruitment and there's fellow development. And just by having these meetings, by having the curriculum, the fellows are already engaged. So at the very minimum, half the mission is working out really well. But what about the other half, and that's equitable recruitment. So I will say from the time of the first FIT-recruited patient up until June 2nd, okay? So, that's February 8 to June 2nd, we account for 16% of all trial sites, but 49% of patients enrolled. Dr. Amit Goyal: Of the patients that we have enrolled, 54% are women compared to 47% for the non-CardioNerds sites. And 80% are BIPOC, or Black, Indigenous and people of color populations, compared to 19% for patients not enrolled by CardioNerds fellows. So, the impact there is, I think it's flooring, honestly. It is earth shattering and we are all amazed by it. And part of the question has been, can this be consistent, right? Is this a fluke? But since, when we had 30 patients enrolled, then we had 35 patients enrolled, we had 40 patients enrolled, these numbers had stayed relatively consistent. Dr. Amit Goyal: The question now is why? How is it that we've been so effective in disproportionately recruiting patients who had been historically underrepresented? And that's a very important question that we are really excited to dive deep into the data and try to understand. So our plans with Rob Mentz and the rest of the people who really made this possible is to really look at the numbers in terms of recruitment. Dr. M. Trejeeve (Tre) Martyn: That's really amazing, guys. And I have to applaud you on the vision to do that, and then to think about how to meet your mission, and then also to meet an unmet need that is... Because clinical trial enrollment, when you go through it, it's always slower than you hope. And this is such a great way to light that, to one, ignite a new generation into how to do clinical trials on the ground floor, but then also to increase the diversity of enrollment is amazing and you guys should be applauded for that. Dr. Vanessa Blumer: I also want to congratulate the both of you. Thank you. You guys are trailblazers and definitely are changing the world for all of us and making it a better place. So, we're so proud of you. We have to wrap up, so maybe just one last question before we go. So, maybe a two-part question, or you can choose to answer one or the other. But what do you guys feel most proud of? And what do you guys think has been the most important lesson that you have learned in the CardioNerds journey so far? Dr. Daniel Ambinder: Thanks, Vanessa. It definitely always helps to emphasize this. We really started this right before COVID. We had no idea COVID-19 would hit. And, really, the whole world was lurched into this virtual space. And there was always the hashtag, in real life? Is this even real life? And there was a sense that maybe it wasn't. And when we went to ACC and we met our people in person, and relationships were, not like they were just starting, but they had been ongoing for years. We really, really felt that this is something so real, and that is the lesson of CardioNerds. The lesson of CardioNerds is that the cardiovascular community is a real cohesive, beautiful community, and there's a lot of CardioNerds out there that embrace their nerdom when it comes to cardiology. Dr. Amit Goyal: I think in terms of what I'm taking away from this journey and what I'm going to keep relying on, the lessons I'm going to keep relying on, are one, is just find something you love and lean in. Right? I mean, when we first started telling people, "Oh, we're going to make a podcast and, hey, by the way, we're going to call the CardioNerds," the reactions we were getting from people, people we deeply respect and look to for advice and for role models, there were a lot of people who said, "Oh, that's great. It's so nice to have a hobby, but what are you going to do during your research block?" Right. That's great. Dr. Amit Goyal: But I think the reason why we've been able to stick with it is because we found something that we genuinely love to do. And so, I think that's really, whatever it is for you, that's really important. I think the second thing that's been extremely important for us is to surround yourself by people who inspire you, who push you, who will advise you, who make you want to be better. And that's people who are senior to you, people who are your peers, people who are junior to you, right? Because you can get as much inspiration from somebody who's 10 years your junior as you can from somebody who's 10 years your senior. Dr. Amit Goyal: I know I've taken a lot of inspiration from Vanessa and Trey and have relied on both of you for advice. I remember Vanessa, I think I had a very, a specific conversation about the clinical trials program when it was just a burgeoning idea way back when. And if number two is to take inspiration, take advice, take mentorship, number three is give. To flip that around and try to just give yourself and make yourself available to as many people around you, because that's how you build a community and that's how you give back and thank the people who give to you. Dr. Maryjane Farr: Okay, great. So, thank you. Thanks all of you. Four contemporaries who are leading the way into the future of cardiovascular medicine, science, and education. So, on behalf of Circulation on the Run, we have been so delighted and honored for you to spend some time with us, have a podcast about the podcasters. But you're not just podcasters, this is a real and amazing and innovative platform, and we are so excited to see where you go next. Any final, last words from Trey and Vanessa or Amit and Dan? Dr. Vanessa Blumer: Thank you so much to Circulation on the Run and Dr. Farr for this opportunity. Amit, Dan, like always, it's such a pleasure. I learn so much from you every single time that I get the opportunity to interact with the both of you and you are an inspiration to all of us. So thank you so much for this platform. Dr. M. Trejeeve (Tre) Martyn: Thanks to Dr. Farr for Circulation on the Run, for this platform, Amit and Dan for taking the time out of their evening to be here, Vanessa, for joining me in Cleveland. And I would say that you guys, the CardioNerds founders, you're an inspiration that you don't necessarily have to wait to make an impact. Dr. Amit Goyal: Yes. Thank you so much. I don't even know what to say. I'm speechless. I'll say that, for Dan and I, we're still just a couple of nerds. I do my recordings in my attic, Dan's in his home office. I think if you, we're still besides ourselves with disbelief that we are a topic of conversation for a platform like Circulation on the Run. It is absolutely a privilege and an honor for us. And so, I think all I can do is just say thank you so much, and then to Dr. Farr for the invitation to have this conversation for Circulation, and Dr. Hill for giving us this platform. I think this is just such a... Again, we are speechless. Thank you. Thank you so much. Dr. Daniel Ambinder: I'm equally as speechless and this podcast, Circ on the Run, really reminds me of my earlier roots, reaching out of my own institution, because it was a Circ social media team that first gave me a great glimpse at what happens outside of the institution that I had been training at for many, many years. And to see how the sausage is made, in terms of how research is vetted and undergoes a strict peer review, was really amazing. And I had the opportunity of meeting Dr. Hill and also being part of the team as COVID was revving up and Circulation had to... We're getting bombarded with all these COVID-related articles. And there was just a very important understanding that what gets published is going to be really, really important. Dr. Daniel Ambinder: So, watching that from the sidelines, under the mentorship of Dr. Amit Kara, just seeing how that happened, gave me such an important understanding that what you put out into the world, whether you're Circulation or writing a personal tweet or putting something out on CardioNerds is just really important and treat it as if it's something that's going to be there forever. And I learned so much about collaboration and I also learned so much about podcasting, because of Circ on the Run, it was actually the first podcast I was on and I don't like to listen to that very often. So thank you so much. This is such an honor to bring this full circle and come back and join you all. Dr. Greg Hundley: This program is copyright of the American Heart Association, 2022. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, please visit ahajournals.org.

    Nosiči vody
    Na Letné odpálili přestupovou bombu. Kuchtovi ale hrozí distanc

    Nosiči vody

    Play Episode Listen Later Jun 28, 2022 60:40


    Slávisté mu nemohou přijít na jméno, sparťané triumfálně slaví. Jan Kuchta se hlásí na Letné coby superposila. Bude moct zasáhnout do úvodního duelu? Co vnese do kabiny Sparty a proč mu hrozí distanc?Chcete si z podcastu vybrat jen některá témata?2:00 Odchod Petra Čecha z Chelsea9:51 Přestupová bomba: Jan Kuchta míří do Sparty 18:45 Koupí Sparta Alexe Krále?29:00 Kuchtův polozapomenutý distanc – odpracuje si ho? 32:10 Silná česká sekce v Jakartě 36:30 Jezero vzpomínek: Útočiště Kypr37:00 Sázkařské okénko: Kurzy na vítěze Fortuna Ligy40:14 Přestupové pohyby v Premier League Jan Kuchta mnohé šokoval, mnohé pobouřil a jiné zase nadchnul. Když letos v zimě přestupoval ze Slavie do Lokomotivu Moskva, těžko by střízlivého fotbalového diváka napadlo, že se bude tentýž rok v létě hlásit jako velkolepá posila Sparty, tedy úhlavního rivala Slavie a zároveň klubu, ze kterého v roce 2013 prchal právě do Edenu. Nosiči vody měli o ústřední téma postaráno.Nejde o trvalý přesunNosiči vody si v novém díle kladli otázku, proč Kuchta raději nezamířil zpět do Edenu, kde ho mnozí fanoušci nedočkavě vyhlíželi už od propuknutí ruské agrese na Ukrajině. Hlad sešívaných po Kuchtově návratu umocnily i jeho bravurní výkony v reprezentačním dresu. „Šíří se zvěsti, že Slavia sice o Kuchtu měla zájem, ale vztahy mezi hráčem a vedením jsou poněkud vyčerpané, když to řeknu kulantně. Další otazník by představovala situace v kabině, jejíž harmonii by příchod Kuchty zřejmě také vyloženě neprospěl. I proto asi Kuchta upřednostnil pražského rivala,“ zamýšlí se Jaromír Bosák, moderátor podcastu Nosiči vody.Nosiči vody Fotbalový podcast Seznam Zpráv. Jaromír Bosák, Luděk Mádl a Karel Tvaroh každý týden o českém a světovém fotbalu. Příběhy, aféry, důležité postavy na hřišti i v zákulisí. Odebírejte na Podcasty.cz, Apple Podcasts nebo Spotify. Sledujte nás na Twitteru! Najdete nás tam jako @Nosicivody. Máte návrh, jak podcast vylepšit? Nebo nás chcete pochválit? Pište na audio@sz.cz.

    Salem: The Podcast
    Interview: Dr. Vitka, Owner of Spellbound Tours

    Salem: The Podcast

    Play Episode Listen Later Jun 28, 2022 90:58


    Paranormal investigator? Bigfoot serenader? UFO believer? Elvis aficionado? Who exactly is the mysterious Dr. Mike Vitka! Joining Jeffrey & Sarah this week is fellow tour guide Mike Vitka, owner of Spellbound Walking Tours. Spellbound has been haunting the streets of Salem for over 20 years as Witch City's original haunted tour. *EXPLICIT WARNING*This episode may not be suitable for young ears. Some grotesque subjects include decapitation, shrunken heads, and Bigfoot erotica. Pursue at own risk!For more info on Mike Vitka & Spellbound Walking Tour tickets visit spellboundtours.com!Instagram - @spellboundtoursEmail - drvitka@spellboundtours.comYou know what to do:www.salemthepodcast.comInstagram - @salemthepodcast Email - hello@salemthepodcast.comYoutube - Salem The PodcastBook a tour with Sarahwww.bewitchedtours.comBook a tour with Jeffreywww.btftours.comIntro/Outro Music from Uppbeat:https://uppbeat.io/t/all-good-folks/unfamiliar-facesLicense code: NGSBY7LA1HTVAUJE

    GamezAttack AudioCast
    GamezAttack AudioCast #456 Why Fallout

    GamezAttack AudioCast

    Play Episode Listen Later Jun 27, 2022


     GAMEZ THAT MR. MIKE HAS PLAYED IN THE PAST WEEK! Yakuza Like A Dragon (Xbox Series X)  > Talking about the lack of gamez and gaming updates from the industry as a whole, Only played Yakuza Like A Dragon and loving all of it, Why people want a New Fallout game sooner than later, And The Gamez Talk Newz..................ENJOY!!!>> Hosted By: Mr. Mike Visit on Twitch.tv/JuJu2Cast - Fridays @8PM EST GameOn!> XboxLive Gamertag: DemonicCore06Theme Music From: FantomenK - Jump Up and Bounce DownBreakMusic From Gamez: Bitrate: 128 Kbps STEREOLength: 1:06:46ListenNow: 

    Queen is Dead - A Film, TV and Culture Podcast
    India via. The Outsider's Gaze | Slumdog Millionaire, Life of Pi & The White Tiger

    Queen is Dead - A Film, TV and Culture Podcast

    Play Episode Listen Later Jun 27, 2022 68:23


    After an unannounced mid-season break, the QID members return to help with Dhruv's film school assignment. Sanjeet, Amartya, and Aryan share their thoughts about Danny Boyle's "Slumdog Millionaire," its controversial legacy, and the "The White Tiger" effect on it. Aryan faces technical difficulties; Sanjeet and Amartya suffer memory deficiency in trying to recall Ang Lee's "Life of Pi." To know their expanded thoughts, listen to the full episode! Do hit 'Follow' on Spotify and rate us, if you haven't already to help the podcast reach more people! Follow our Instagram page: https://instagram.com/queenisdead.filmpodcast You can also follow us on Instagram at: Aryan: https://www.instagram.com/aryantalksfilm/ Sanjeet: https://www.instagram.com/pixel_baba/ Amartya: https://www.instagram.com/amartya25/ Dhruv: https://www.instagram.com/terminalcinema/ Do hit 'Follow' on Spotify if you haven't already to help the podcast reach more people! Follow us on Letterboxd at: Dhruv: https://letterboxd.com/aterminalcinema/ Sanjeet: https://letterboxd.com/Sanjeet_Singh/ Aryan: https://letterboxd.com/aryantalksfilms/ Amartya: https://letterboxd.com/amartya/ --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/queenisdead/support

    Another MMA Podcast
    Episode 1 UFC 276 Embedded (AMP'd)| #UFC #UFC276

    Another MMA Podcast

    Play Episode Listen Later Jun 27, 2022 9:41


    Champ Israel Adesanya shoots hoops and gets pranked. Champion Alexander Volkanovski and rival Max Holloway both question their travel plans. Sean O'Malley uses breath to stay focused. The Anzac athletes hit the PI. #UFC

    Remembering Yugoslavia
    Fićo Goes Back to the Future

    Remembering Yugoslavia

    Play Episode Listen Later Jun 27, 2022 57:11


    There's a Yugoslav car that was even more important than the Yugo for the country and for the country's memory. Better known by its nickname, Fića / Fićo / Fićko, Zastava 750 was the first Yugoslav car. It was and continues to be a Yugoslav icon, a symbol of that disappeared country and an object of nostalgia. In metaphorical terms, Fićo is Yugoslavia…and probably always will be. This is Fića's story.With Martin Pogačar and Jovana Stojilković. Featuring the song "Piči Fića" by Sabrija Vulić.The Remembering Yugoslavia podcast explores the memory of a country that no longer exists. Created, produced, and hosted by Peter Korchnak. New episodes two to three times per month.Shownotes/transcript: RememberingYugoslavia.com/Podcast-Fico-Zastava-750/Instagram: @RememberingYugoslaviaSUPPORT THE SHOW ›Support the show

    Crawlspace: True Crime & Mysteries
    292 // I Said God Damn!

    Crawlspace: True Crime & Mysteries

    Play Episode Listen Later Jun 26, 2022 49:27


    Welcome to Crawlspace. In this week's episode, Tim & Lance are joined by new friends and colleagues in the podcasting industry, Erin & Stacey creators and hosts of the I Said God Damn! true crime comedy podcast. No topic is left on the table during this wildly entertaining conversation.  For more information on I Said God Damn!, go to: https://isgdpodcast.com/ For more information on Erin & Stacey's “Operation Moonblood” charity go to: https://isgdpodcast.com/operation-moon-blood/ Listen to ISGD: Apple: https://podcasts.apple.com/us/podcast/i-said-god-damn-a-true-crime-podcast/id1437090622 Spotify: https://open.spotify.com/show/5PCfGN9QRAPyD6RjTAsHA0?si=a1f1ada93f734c7c  Don't miss the True Crime Obsessed Tour as we visit a city near you! Get your tickets here: https://www.truecrimeobsessed.com/see-us-live Check out Wondery's Persona: The French Deception wherever you get your podcasts. Download Best Fiends from the App Store or Google Play today! For ad-free (and more!) episodes, including this one, please check out our Crawlspace subscription service at https://crawlspace.supportingcast.fm/ Check out our Missing subscription service where we have a bonus show and ad-free episodes! https://missing.supportingcast.fm/ Follow us on Twitter: https://twitter.com/crawlspacepod  Follow us on Facebook: https://www.facebook.com/Crawlspacepodcast  Follow us on Instagram: https://www.Instagram.com/Crawlspacepodcast Follow us on TikTok: https://www.tiktok.com/@crawlspacepodcast The music for Crawlspace was produced by David Flajnik. Listen to his music here: https://www.pond5.com/artist/bigdsound  Check out our entire network at http://crawlspace-media.com/ Join the Crawlspace Discussion Facebook group: https://www.facebook.com/groups/talkcrawlspace/ Crawlspace Media is part of the Glassbox Media Network. Check them out here: https://glassboxmedia.com/ Go to https://smile.amazon.com/ to connect your existing Amazon account to donate to PI's For the Missing. Follow Private Investigations For the Missing https://investigationsforthemissing.org/ http://piftm.org/donate https://twitter.com/PIFortheMissing https://www.facebook.com/PIFortheMissing/ https://www.instagram.com/investigationsforthemissing/ Learn more about your ad choices. Visit megaphone.fm/adchoices

    Radio 24 Podcast
    Strade e Motori - Neutralità tecnologica e diversificazione delle alimentazioni

    Radio 24 Podcast

    Play Episode Listen Later Jun 25, 2022


    Torna con il nuovo anno in un nuovo formato l'appuntamento con Strade e motori, a cura di Massimo De Donato, ogni sabato alle 22 . Più spazio a interviste approfondimenti e soprattutto prove su strada. Conosceremo l'evoluzione delle auto elettriche ed ecologiche, nuovi motori ibridi, nuovi modelli e tutto ciò che riguarda l'impatto dell'auto sulla vita quotidiana di tutti noi, dai divieti di circolazione nei giorni festivi, ai nuovi incentivi per l'acquisto sino ad arrivare all'ecotassa che dal prossimo mese di marzo penalizzerà chi acquisterà veicoli inquinanti. Scopri anche tutte le prove su strada su AutoVideoClip

    La table des bons vivants - Laurent Mariotte
    Jean-François Piège sur le grill

    La table des bons vivants - Laurent Mariotte

    Play Episode Listen Later Jun 25, 2022 10:57


    Chaque samedi, Laurent Mariotte et ses chroniqueurs passent l'invité sur le grill : une interview qui permet d'en savoir plus sur les goûts culinaires de notre personnalité de la semaine. Aujourd'hui, Jean-François Piège. 

    Dead Pilots Society
    Episode 96: Lenny written by Lucas Hazlett (Amercan Princess) & Alex Herschlag (Will & Grace)

    Dead Pilots Society

    Play Episode Listen Later Jun 23, 2022 43:07


    We're kicking off summer 2022 with a wonderful pilot! It's called Lenny written by Lucas Hazlett (Wrecked, American Princess) & Alex Herschlag (Will & Grace, Modern Family). Lenny centers around a gay half black half white man child who moves in with his white mother and her new white fiancé on the condition that he becomes the nanny to the fiancé's children. It was written for CBS and it's just a ton of fun. Our cast for this pilot includes Lucas Hazlitt as Lenny, Suzanne Cryer (Silicon Valley) as Elizabeth Harris, Amy Hill (magnum PI) as Dr. Chang, Ru Kazi (The Good Place) as Al Clark, Jiavani (Between Two Ferns) as Crystal, Emma Shannon (Better Things) as Madeline, Jay Pichardo (NCIS: Los Angeles) as Jason, Antonio Corbo (Brooklyn 99) as Tristan, and Andrew Reich with stage directions. Tune in next week for our interview with Lucas and Alex. Thanks for supporting our show! Enjoy!For more Dead Pilots Society episodes and information about our live shows, please subscribe to the podcast!Make sure to like us on Facebook, follow us on Instagram, and Twitter, and visit our website at deadpilotssociety.com

    New Books in Biography
    Joshua D. Zimmerman, "Jozef Pilsudski: Founding Father of Modern Poland" (Harvard UP, 2022)

    New Books in Biography

    Play Episode Listen Later Jun 23, 2022 98:35


    In the 1920s, Józef Piłsudski was a household name not just in Poland, but across Europe and across the Atlantic Ocean as well. Yet this complex and contradictory figure – a socialist and a nationalist, a clandestine agitator and a legendary military strategist, protector of Jews and other national minorities on Polish soil who was nonetheless often accused of imperialism – has eluded serious biographical treatment in English until now. Yeshiva University professor Joshua D. Zimmerman offers a nuanced, readable, and definitive account of the man who re-founded the independent state of Poland in 1918. Jozef Pilsudski: Founding Father of Modern Poland (Harvard University Press, 2022) could not be more timely, given the lessons to be learned from Piłsudski's career by today's opponents of far-right populism in Eastern Europe, and even more urgently – by English-language readers seeking to understand the imperative of preserving an independent Ukrainian state in the face of Russian aggression. Piotr H. Kosicki is Associate Professor of History at the University of Maryland, College Park. He is the author of Catholics on the Barricades (Yale, 2018) and editor, among others, of Political Exile in the Global Twentieth Century (with Wolfram Kaiser). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/biography

    New Books Network
    Joshua D. Zimmerman, "Jozef Pilsudski: Founding Father of Modern Poland" (Harvard UP, 2022)

    New Books Network

    Play Episode Listen Later Jun 23, 2022 98:35


    In the 1920s, Józef Piłsudski was a household name not just in Poland, but across Europe and across the Atlantic Ocean as well. Yet this complex and contradictory figure – a socialist and a nationalist, a clandestine agitator and a legendary military strategist, protector of Jews and other national minorities on Polish soil who was nonetheless often accused of imperialism – has eluded serious biographical treatment in English until now. Yeshiva University professor Joshua D. Zimmerman offers a nuanced, readable, and definitive account of the man who re-founded the independent state of Poland in 1918. Jozef Pilsudski: Founding Father of Modern Poland (Harvard University Press, 2022) could not be more timely, given the lessons to be learned from Piłsudski's career by today's opponents of far-right populism in Eastern Europe, and even more urgently – by English-language readers seeking to understand the imperative of preserving an independent Ukrainian state in the face of Russian aggression. Piotr H. Kosicki is Associate Professor of History at the University of Maryland, College Park. He is the author of Catholics on the Barricades (Yale, 2018) and editor, among others, of Political Exile in the Global Twentieth Century (with Wolfram Kaiser). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

    New Books in History
    Joshua D. Zimmerman, "Jozef Pilsudski: Founding Father of Modern Poland" (Harvard UP, 2022)

    New Books in History

    Play Episode Listen Later Jun 23, 2022 98:35


    In the 1920s, Józef Piłsudski was a household name not just in Poland, but across Europe and across the Atlantic Ocean as well. Yet this complex and contradictory figure – a socialist and a nationalist, a clandestine agitator and a legendary military strategist, protector of Jews and other national minorities on Polish soil who was nonetheless often accused of imperialism – has eluded serious biographical treatment in English until now. Yeshiva University professor Joshua D. Zimmerman offers a nuanced, readable, and definitive account of the man who re-founded the independent state of Poland in 1918. Jozef Pilsudski: Founding Father of Modern Poland (Harvard University Press, 2022) could not be more timely, given the lessons to be learned from Piłsudski's career by today's opponents of far-right populism in Eastern Europe, and even more urgently – by English-language readers seeking to understand the imperative of preserving an independent Ukrainian state in the face of Russian aggression. Piotr H. Kosicki is Associate Professor of History at the University of Maryland, College Park. He is the author of Catholics on the Barricades (Yale, 2018) and editor, among others, of Political Exile in the Global Twentieth Century (with Wolfram Kaiser). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

    New Books in Eastern European Studies
    Joshua D. Zimmerman, "Jozef Pilsudski: Founding Father of Modern Poland" (Harvard UP, 2022)

    New Books in Eastern European Studies

    Play Episode Listen Later Jun 23, 2022 98:35


    In the 1920s, Józef Piłsudski was a household name not just in Poland, but across Europe and across the Atlantic Ocean as well. Yet this complex and contradictory figure – a socialist and a nationalist, a clandestine agitator and a legendary military strategist, protector of Jews and other national minorities on Polish soil who was nonetheless often accused of imperialism – has eluded serious biographical treatment in English until now. Yeshiva University professor Joshua D. Zimmerman offers a nuanced, readable, and definitive account of the man who re-founded the independent state of Poland in 1918. Jozef Pilsudski: Founding Father of Modern Poland (Harvard University Press, 2022) could not be more timely, given the lessons to be learned from Piłsudski's career by today's opponents of far-right populism in Eastern Europe, and even more urgently – by English-language readers seeking to understand the imperative of preserving an independent Ukrainian state in the face of Russian aggression. Piotr H. Kosicki is Associate Professor of History at the University of Maryland, College Park. He is the author of Catholics on the Barricades (Yale, 2018) and editor, among others, of Political Exile in the Global Twentieth Century (with Wolfram Kaiser). Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/eastern-european-studies

    PI’s Declassified!
    Encore Outrageous Gumshoe Stories

    PI’s Declassified!

    Play Episode Listen Later Jun 23, 2022 58:29


    Whenever a group of private investigators get together, there are war stories. Sometimes, no matter how much planning has taken place ahead of time, the law of Murphy does its work. This particularly true for those private investigators who specialize in surveillance and worker's compensation fraud. If a situation is going to go south, it has a high probability of happening during a surveillance, whether it is moving or stationary. Join Scott Fulmer, a private investigator who has many outrageous stories to share from his experiences over the past 20 years.

    Crawlspace: True Crime & Mysteries
    291 // Who Is The Gentleman of Heligoland?

    Crawlspace: True Crime & Mysteries

    Play Episode Listen Later Jun 22, 2022 50:04


    Welcome to Crawlspace. In this episode, Tim & Lance speak with old friend Ken Davies from the Fred the Head podcast about his new obsession, The Gentleman of Heligoland. Ken has teamed up with his mate Iain Mackay and together they are determined to solve this decades old mystery: In July 1994, the body a man was fished out of the North Sea, near the German Island of Heligoland. Dressed smartly and with a complete absence of identifying information, the body was simply named ”The Gentleman”. Nearly thirty years later is still unnamed and unclaimed. Listen to The Mysterious Case of the Gentleman of Heligoland here: https://podcasts.apple.com/gb/podcast/the-mysterious-case-of-the-gentleman-of-heligoland/id1610978724 Listen to Fred the Head here: https://podcasts.apple.com/us/podcast/the-mysterious-case-of-fred-the-head/id1557099549 Articles referenced for this episode: https://www.theguardian.com/world/2022/apr/28/heligoland-the-gentleman-researchers-mystery-german-cold-case-marks-spencer https://metro.co.uk/2022/02/03/bid-to-identify-brit-dubbed-the-gentleman-found-at-sea-28-years-ago-16044837/ https://www.mirror.co.uk/news/uk-news/push-identify-brit-dubbed-gentleman-26122792 Don't miss the True Crime Obsessed Tour as we visit a city near you! Get your tickets here: https://www.truecrimeobsessed.com/see-us-live For ad-free (and more!) episodes, including this one, please check out our Crawlspace subscription service at https://crawlspace.supportingcast.fm/ Check out our Missing subscription service where we have a bonus show and ad-free episodes! https://missing.supportingcast.fm/ Follow us on Twitter: https://twitter.com/crawlspacepod  Follow us on Facebook: https://www.facebook.com/Crawlspacepodcast  Follow us on Instagram: https://www.Instagram.com/Crawlspacepodcast Follow us on TikTok: https://www.tiktok.com/@crawlspacepodcast The music for Crawlspace was produced by David Flajnik. Listen to his music here: https://www.pond5.com/artist/bigdsound  Check out our entire network at http://crawlspace-media.com/ Join the Crawlspace Discussion Facebook group: https://www.facebook.com/groups/talkcrawlspace/ Crawlspace Media is part of the Glassbox Media Network. Check them out here: https://glassboxmedia.com/ Go to https://smile.amazon.com/ to connect your existing Amazon account to donate to PI's For the Missing. Follow Private Investigations For the Missing https://investigationsforthemissing.org/ http://piftm.org/donate https://twitter.com/PIFortheMissing https://www.facebook.com/PIFortheMissing/ https://www.instagram.com/investigationsforthemissing/ Learn more about your ad choices. Visit megaphone.fm/adchoices

    ASCO eLearning Weekly Podcasts
    Cancer Topics - Career Paths in Oncology (Part 1)

    ASCO eLearning Weekly Podcasts

    Play Episode Listen Later Jun 22, 2022 26:24


    In part one, of this two-part ASCO Education podcast episode, host Dr. Jeremy Cetnar (Oregon Health & Science University) interviews two very accomplished physicians and researchers, Dr. Lauren Abrey and Dr. Jason Faris. We'll hear about their motivations for pursuing medicine and how they arrived at the different positions they've held in academia and industry.  If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at education@asco.org.   TRANSCRIPT   Dr. Jeremy Cetnar: Hello, and welcome to the ASCO Education podcast episode on career paths and oncology. My name is Jeremy Cetnar. I'm a Medical Oncologist and Associate Professor of Medicine at Oregon Health and Science University in Portland. I'm delighted to introduce today's two guests, whose careers in oncology have crisscrossed academia and industry. Dr. Lauren Abrey and Dr. Jason Faris, I'm excited to chat with you about the inspiration and motivations that drive you, people you've leaned on, how you've made your career decisions, challenges you've faced, and more.  So let's start by asking each of you, could you share a little bit about your early life and background, what attracted you to medicine, and who are some of your early mentors and role models? Let's start with you, Dr. Faris.  Dr. Jason Faris: Yeah, I'd be happy to. Thank you. So, I grew up in a small town in South Jersey in Greater Philadelphia. My mom was a registered nurse in pediatrics in the maternal infant unit for many years at Cooper Hospital. I was always interested in science and medicine and my mom's dedication to her patients. Her altruism and compassion served as a real inspiration for me, for my eventual decision to go to medical school. But I took a long time to get there. I had a bit of a circuitous route to arrive to my career in medicine though it started off conventionally enough. I was initially geared towards a premedical track in college, majoring in biology, but an exciting summer research project, working on the biochemical mechanisms underlying osmoregulation in a marine crustacean with mentoring from my first true mentor, Dr. Don Lovett, led me to apply to and attend graduate school in molecular biology at Princeton.  This was followed by a position at Merck as a molecular biologist in the genetic and cellular toxicology group. I went to veterinary school at the University of Pennsylvania where I met my future wife. And then finally, back to the original plan of attending medical school, but I have to say with a much better sense of why I wanted to attend medical school in the first place, now in my late 20s, which was a bit unconventional at the time. I really did my fair share of exploration of Allied Health careers. That's for sure. I attended Johns Hopkins for medical school, where I quickly discovered a passion for internal medicine. And that was far and away my favorite clerkship and sub-internship. That's the background to how I got to medical school.  Dr. Jeremy Cetnar: Dr. Abrey?  Dr. Lauren Abrey: Interesting. I love your story. We share... I grew up in a small town, not so far away, but I was in upstate New York. And I think there were two influences that kind of got me to my ultimate passion for brain tumors. And this sounds a little quirky to start with. But I had a pretty serious head injury as a tween. So I guess I was about 12. I had a skull fracture, epidural hematoma. And while I would never have said I woke up at that moment and thought I have to be a doctor, I think I became fascinated about things to do with the brain.  In parallel, something that I think tinged a lot of my childhood was a number of family members who had cancer. So both of my grandmothers had breast cancer, while I was well aware of the fact that they were sick and battling this. And two of my aunts also had cancer. And I would say it's an interesting split in my family. So about half of them are survivors and about half ultimately died of their disease.  So both of these things really motivated me or focused me on the need to do something important, but also to do something that really motivated me to get out of bed in the morning. I think I was much more to the point. I went straight to college, straight to medical school. I remember calling my parents and telling them I was applying to medical school and having them say, “Wait. You? Really?” So it wasn't necessarily the family expectation that I would do this, but I was very driven and motivated to make some of these choices and then discover my particular interests as I progressed through medical school. So I went to Georgetown for medical school and then have trained at a number of places in the US. I think that's a little bit how I took my first step on this career journey, let's say.  Dr. Jeremy Cetnar: So take us through what the decisions were like in your head at the end of fellowship in terms of first jobs. Dr. Faris?  Dr. Jason Faris: In terms of my choice to pursue a career in medical oncology, this goes back to medical school during an internal medicine clerkship. I had an assistant chief of service, ACS, at the time, Phil Nivatpumin. He'd go on to become a medical oncologist. He really inspired me with his optimism and bedside manner, including with multiple oncology patients on that clerkship. His enthusiasm for science and medicine, his teaching skills, and an absolutely legendary fund of knowledge. For Phil, he was just an incredible ambassador for both internal medicine and for oncology.  After medical school, I went to internship and residency at Mass General Hospital. And in one of my first rotations, I was on the oncology service, which was not so creatively called Team Three. I think they can up the ante there, but oncology services on Team Three. I was caring for many extremely ill patients battling disease progression from their metastatic cancers, or sadly, in many cases complications of their treatments. During that rotation, I was intrigued by clinical trials offering novel treatment options based on cutting edge science, but also struck by the number of patients who just didn't have any clinical trial options. I became aware of the limitations of the conventional treatments that were offered.  I was really inspired by the patience and dedication of the nurses and doctors caring for them. And I vividly recall a roughly 50-year-old woman I helped care for with AML, watching as the 7+3 chemotherapy caused lots of side effects for her and being amazed by her strength and grace, her resilience as she faced her illness, her potential mortality, and the intense chemotherapy she was undergoing. And I knew during those moments with that leukemia patient while caring for other patients on that oncology service that this was the field I would pursue. Oncology was really the perfect blend of humanism, problem solving, longitudinal follow-up and rapidly accelerating scientific progress leading to new avenues for clinical trial treatments.  Like Lauren, I was motivated and inspired by cancer diagnoses in my own family. My maternal grandmother died of pancreatic cancer during my junior year of college. My dad was diagnosed with colon cancer during my first year of fellowship. So those are all really strong motivators, I would say. And after completing my fellowship at the combined Dana-Farber MGH program, my first position out of fellowship was in the gastrointestinal cancer group at MGH. I actually had been training in genitourinary oncology after my main clinically focused year of fellowship, but I did a chief resident year in the middle of fellowship, and that was the tradition at MGH. And as I was about to return to fellowship for my senior year of fellowship, the head of the GI Group and head of the Cancer Center at the time, Dave Ryan, offered to serve as a clinical research mentor for me in GI cancers. As a senior fellow, I wrote an investigator-initiated trial of cabozantinib for patients with neuroendocrine tumors under his mentorship that went on to demonstrate encouraging results, led to a Phase III study in that cancer population, and I ultimately accepted a position at the MGH Cancer Center in the GI cancer group about 11 years ago. And that was the start of my post-training career.  Dr. Jeremy Cetnar: And how about you, Dr. Abrey?  Dr. Lauren Abrey: So for people who don't know, I'm actually a neurologist. I finished my training in neurology and then pursued a fellowship in neuro oncology. I would say it was really patients and observations of things that were happening with patients during my residency. I did my residency at the University of Southern California at Los Angeles. I was at the LA County Hospital, which for people who don't know, is one of the largest hospitals in the country. I had the chance to see several patients who had paraneoplastic syndromes, and got the support from different faculty members to write those cases up, and really resulting in my first independent publications. That was what kind of got me bitten by the bug to understand this link between neurology and oncology.  I very intentionally went to Memorial Sloan Kettering to have the opportunity to work with Jerry Posner. And I think I no sooner got there than I got totally bitten by the brain tumor bug, which seems a little counterintuitive. But the paraneoplastic work was kind of deep laboratory work. And I realized that I really enjoyed seeing the patients having the partnership with neurosurgeons and digging into what is still a pretty intense unmet medical need.  So it was an interesting pivot because I really thought I was going to Sloane to focus on paraneoplasia. I still think I learned so much with that interest that I think we can reflect on when we consider how immunology has finally entered into the treatment landscape today for different tumor types and understanding is there a background in paraneoplastic disorders that could help us. But I have to say it was really the brain tumor work that got me focused and the chance to work with people like Lisa DeAngelis, Phil Gutin, and others that was kind of fundamental to my choices. I stayed there for two years of fellowship and then continued as faculty for about another 15 years at Sloan Kettering. So that's really the start of my academic career and the pivot to industry came much later.  Dr. Jeremy Cetnar: So both of you have impressive career CVs, have been trained at very prestigious institutions. So at some point in time, take me through, what was that transition like between, 'Hmm, what I'm doing is enjoyable, but maybe there's something else out there that I want to explore.' And what I mean by that is mostly industry at this point. So that's an important question that I think a lot of junior faculty face, a lot of mid-career faculty, maybe even later-stage faculty. But I think that's a tension point for a lot of people because I think there's a lot of fear. I think there's a lot of anxiety about moving outside of the academic realm. So, tell us a little bit about what was the pull in terms of going to industry and what were some of the thought processes that were going on. Dr. Faris?    Dr. Jason Faris: I've experienced two transitions, actually, between academia and industry. I like to do things in pairs, I guess. But the first was, after multiple years at the MGH as a resident fellow and as a clinical investigator at the MGH Cancer Center. As a new attending and clinical investigator, I was attempting to balance my work priorities, providing patients with GI cancers, which is a rewarding but complex and I'd say emotionally intense experience, given the phenomenally aggressive and devastating cancers these patients grapple with such as pancreatic cancer, alongside the other responsibilities of my clinical investigator position.  Those other responsibilities included writing grants and papers and protocols, evaluating patients who were interested in open clinical trials, and serving as the principal investigator for multiple studies. I was serving on committees, mentoring and teaching. Patient care was always my top priority as it should and really must be. And I feel incredibly lucky to have had truly amazing colleagues at MGH across several disciplines, from medical oncology, nurse practitioners, practice nurses, radiation oncologists, and surgeons. It was and continues to be a dynamic place full of extremely talented and dedicated clinicians. I think we really all benefited from the coordinated teamwork in both patient care and research in a really tight-knit GI Group.  But nonetheless, for me as someone who delighted in spending large amounts of time with my patients in the clinic rooms, and I think my colleagues would agree frequently agonizing over decisions impacting their care, achieving sufficient balance to really focus on writing and overseeing clinical trials was becoming increasingly challenging for me. And it was in that context, after spending roughly a decade and the combination of residency fellowship training and as an attending in the GI cancer group all at MGH that I made a truly difficult decision to move from my beloved outpatient clinical and clinical investigator role to industry to focus more exclusively on clinical research.  And after interviewing for several industry-based roles, I accepted a position in the early-phase group at the Novartis Institutes for Biomedical Research or NIBR as we kind of pronounced those words in Cambridge. I absolutely loved my time at NIBR. It's an incredible place with a strong history of and commitment to innovation as well as passionate, talented colleagues, many of whom I've worked with in the past. When I first started at Novartis, I was amazed at the array of experts on the teams I was helping to lead as a clinical program leader. Our teams are the definition of multidisciplinary. They're composed of what we call line function experts in multiple disciplines. This includes preclinical safety experts who design and analyze data from studies that precede the filing of an IND, research scientists, chemists, preclinical, and clinical pharmacologists, statisticians, program managers, drug and regulatory affair colleagues, who focus on the interactions with health authorities, including the FDA, operational colleagues called clinical trial leaders, and many others.  In my role as a senior clinical program leader, I also have the opportunity to collaborate frequently with research colleagues on preclinical programs, designing and writing first in human trials, followed by conducting the actual studies and in close collaboration with our academic colleagues, analyzing the clinical and translational results.  Dr. Jeremy Cetnar: Dr. Abrey, how about you? Was there a moment or what were the moments that led to you deciding to make this transition?  Dr. Lauren Abrey: I guess I have the other sort of story. I got pushed, I would say, in the sense that like many of us, I'm married, and my husband was the one who took a job with Novartis and said, “This would be an adventure. Let's go live in Switzerland.” So similar to Jason, he took a position at NIBR, and I think for many of the same reasons, he really wanted to delve deeply into early mechanism of action and allow himself to dedicate really a chunk of his career to developing key drugs. But moving to Switzerland changes your options suddenly. I think I had spent most of my career at Sloan Kettering doing clinical trials. That was really my comfort zone, my sweet spot. And when we moved over here, I explored briefly, could I set up an academic career here?  And very kindly, I was invited by a number of Swiss colleagues to look for opportunities to do that. But I realized what I loved was talking to patients, and that that was going to be difficult with the language barrier. And I equally loved running clinical trials. So I had a great opportunity to join Roche shortly after their merge or full acquisition of Genentech. This allowed me to continue the work I had been doing on Avastin for brain tumors.  But I think the other thing that allowed me to do, that was something I was really looking for was to broaden my scope and to no longer be niched as just a brain tumor expert. And if you're in academia and you're a neurologist, obviously, you're going to be fairly constrained in that space. But moving into a role in industry really allows you to look much more broadly and work across multiple tumor types. And I spent the next seven years at Roche running not just the Avastin teams that were developing drugs for a number of indications, but really overseeing the clinical development group based in the European sites. And they had about 14 different drugs in different stages of development as well as partnerships with their early research group that was European based.  So it was a fascinating time for me, and I feel kind of like I got thrown into the pond. I knew a lot about clinical trials. I had no idea about so many other aspects of what I needed to consider. And I think Jason started to allude to some of this with the different line function expertise and things I think we take for granted or maybe we simply have blind spots around them when we are sitting in our academic organizations. So it's been a really delightful plunge into the pool. I've continued to swim mostly. Occasionally, a little bit of drowning, but a lot of fun.  Dr. Jeremy Cetnar: What would you say are the major differences between an academic career and industry?  Dr. Lauren Abrey: I think, as you said, the things that are similar is that the purpose or the mission for both is in many ways the same. We would like to develop better treatments for patients with cancer. And so there's a huge focus on clinical trials. There needs to be a huge focus on patients, and that can get diluted in industry. I think the things that you don't appreciate sometimes when you're sitting on the academic side is just really the overarching business structure and the complexity of some of the very large organizations. So you suddenly are in this huge space with people focused on regulatory approvals focused on pricing, focused on manufacturing, focused on the clinical trial execution, and why you are doing it in different spots.  And so I think some of the different factors that you have to consider are things that again, we either take for granted or are super focused when you're in one organization. And I think the tradeoffs and how decisions are made, particularly in large pharma, can be frustrating. I think we are all used to applying for grants or getting the funding we need to do whatever our project or trial is. And then you just start very laser focused on getting to the end. If you're in a large organization and they have a portfolio where they're developing 14, 15, 20 different things, you might suddenly find that the project you think is most important gets de-prioritized against something that the company thinks is more critical to move forward. And that could be because there's better data, but it could also be because there's increasing competition in the space or there's a different pull for a large company. I haven't seen the early development side as much. I've seen the development. I've now seen Medical Affairs for how some of those decisions are made, but I'd be curious to hear what Jason has seen in some of his experiences as well.  Dr. Jason Faris: Comparing and contrasting a little bit between the two, because I've run early phase studies on the academic side, I'll talk more about that in a little bit in terms of another academic position that I held. So I've run early-phase studies there. I've run early-phase studies in industry as well. And they share a lot of similarities, certainly following compelling science, the excitement about new therapies that are going to be offered to patients. But I think the execution is a bit different, and I would say, when you're running clinical trials in the academic setting, you're meeting every patient that you're going to put on study or at least one of your colleagues is, if you have sub-eyes on the study, that's a major, major difference, right? You're directly taking care of a patient going on to an experimental therapy, consenting that patient, following them over time, getting the firsthand experience and data from that patient interaction, but not necessarily, unless you're running an investigator-initiated study, not necessarily having access to the data across the whole study.  You're hearing about the data across the whole study at certain time points on investigator calls, PI meetings, dose escalation meetings, those kinds of things. But you're not necessarily having access to the real-time emergence of data across the whole study from other people's patients. So you're a bit dependent on the sponsor to provide those glimpses of the data, synthesize that and present overview. So those are some operational differences, I would say, because you're not taking direct care of the patients and having your time split among different commitments in that way I have felt a greater ability to focus on the clinical research that I'm doing in my industry-based role, which I like, of course, but I also miss taking care of patients. I love taking care of patients.   So I think it's always a double-edged sword with that if we can use a sword analogy here. But I think they both offer really exciting options to pursue new therapies for patients, which for me, was one of the fundamental reasons that I pursued medical oncology in the first place. It was really this idea that the field is rapidly advancing. I wanted to be a part of that. I saw firsthand what cancer could do to my family or family members, and I took care of patients in the hospital as an intern resident and fellow where I think there's just a tremendous unmet medical need. And so having an opportunity to contribute to the development of new therapies was always a real inspiration for me.  Dr. Jeremy Cetnar: With that being said, what led you to go back into academia?  Dr. Jason Faris: This is an ongoing saga, I guess. So after several years of professional growth at Novartis, gaining experience with designing and conducting clinical trials on the industry side, I was actually at ASCO and I learned of an open role for the director of the early phase trials program at Dartmouth's Cancer Center. After extensive consideration, which I think you can see as my trademark at this point, I made another difficult decision to interview for the position, which was focused on helping to grow the early phase trials program at an NCI comprehensive designated cancer center that's unique in a way because it's in a rural area. And it had a new director of the Cancer Center, Steve Leach, who's a renowned laboratory scientist with a focus on pancreatic cancer and a surgeon by training.  I ultimately decided to accept the early phase director position, moving my family away from Greater Boston, where we had lived for about 15 years, to the upper valley of New Hampshire. And while at Dartmouth, I was part of exciting projects, including writing and overseeing an NCI grant called Catch Up, which was geared towards improving access to early phase clinical trials for rural patients. I opened numerous sponsor-initiated immunotherapy and targeted therapy, early phase trials. Just to say a little bit about Dartmouth's Cancer Center - I think they also benefit from tremendous collaboration, this time across Dartmouth College, the Geisel School of Medicine, the School of Public Health. I think they provide really excellent care to their cancer patients. And I was extremely proud to be part of that culture in the GI Group, which was much smaller than the one at MGH, but also an incredibly dedicated group of multidisciplinary colleagues who work tirelessly to care for their patients.  But nonetheless, less than six months into that new position, the COVID pandemic started, and that introduced some significant and new challenges on the clinical trials side in terms of staffing, infrastructure, those kinds of things. In that context, I made a decision to return to NIBR, refocus on clinical research, and hope to harness my background in running clinical trials in both settings, both academic and industry, as well as the resources and pipeline of Novartis to really maximize my impact on drug development. So for me, it was a question of where can I have the maximum impact at this crazy time, difficult time. I saw that my best option was to return to industry to work on studies to try to develop new therapies. Broadly speaking, my role as a senior clinical program leader in the translational and clinical oncology group at NIBR is to design, write, conduct, and analyze innovative clinical trials of early phase therapeutics.  Dr. Jeremy Cetnar: Wow, that's fascinating, very, very interesting. A lot of stress. You should definitely be buying lots of presents for your family for moving them all over the place.  This concludes part one of our interview with Drs. Abrey and Faris. Thank you so much for sharing your inspiring career stories. And thank you to all our listeners for tuning into this episode of the ASCO Education Cancer Topics podcast.  Thank you for listening to the ASCO Education podcast. To stay up to date with the latest episodes, please click subscribe. Let us know what you think by leaving a review. For more information, visit the Comprehensive Education Center at education.asco.org.    The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions.  Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. 

    My Favorite Detective Stories
    Emilya Naymark | My Favorite Detective Stories Episode 166

    My Favorite Detective Stories

    Play Episode Listen Later Jun 21, 2022 50:10


    Emilya Naymark was born in a country that no longer exists, escaped with her parents, lived in Italy for a bit, and ended up in New York, which promptly became a love and a muse.She is the author of the novels Hide in Place and the upcoming Behind the Lie, out February 8, 2022.Her short stories appear in A Stranger Comes to Town, edited by Michael Koryta, Secrets in the Water, After Midnight: Tales from the Graveyard Shift, River River Journal, Snowbound: Best New England Crime Stories 2017, When not writing, Emilya works as a visual artist and reads massive quantities of psychological thrillers, suspense, and crime fiction. She lives in the Hudson Valley with her family.https://www.amazon.com/Emilya-Naymark/e/B07XX96LCB/ref=dp_byline_cont_pop_book_1 Today's episode is brought to you by John's full series of crime thrillers available right now. You can get them through Amazon here: https://www.amazon.com/John-A.-Hoda/e/B00BGPXBMM%3Fref=dbs_a_mng_rwt_scns_share  You can also sign up for the newsletter at http://www.JohnHoda.com to get a free copy of John's new novella Liberty City Nights. Thank you for listening. If you have a moment to spare please leave a rating or comment on Apple Podcasts as that will help us expand the circle around our campfire. If you have any questions please feel to reach out to me via my website http://www.johnhoda.com

    Silicon Carne, un peu de picante dans la Tech

    Si jevous dis Digital Nomade, je sais à quoi vous pensez. Vous imaginez sans doute un expat au Costa Rica en train de poster un selfie dans son hamac, son ordinateur sur les genoux et une Piña Colada à portée de main avec en guise de légende “Mon bureau pour la journée…” C'est vrai qu'avec la pandémie de plus en plus de monde a fait le choix d'une vie nomade pas forcément d'ailleurs à l'autre bout du monde. Les chiffres le montrent, les travailleurs du numérique sont de plus en plus nombreux à prendre le large et à travailler loin des mégalopoles devenues trop coûteuses et anxiogènes. Les gens ne veulent plus vivre là où se trouve leur travail, ils veulent travailler là où ils vivent.Alors sommes-nous à l'aube d'un changement profond de nos modes de vie et de travail ou bien est-ce que ce mouvement nomadique n'est qu'une passade réservé à quelques privilégiés de la mondialisation en quête de sens ? Est-ce que le modèle itinérant est adapté à une vie professionnelle et familiale épanouie ?—Nos invités: Kristofer Moisan, Founder & CEO of WYTLAND et Augustin Delaporte, VP of Product Management at Platform.sh

    Conocimiento Experto
    286 - El Efecto de la Expectativa - Lecturas Recomendadas Conocimiento Experto

    Conocimiento Experto

    Play Episode Listen Later Jun 20, 2022 43:38


    ¿Qué hay para mi dentro del libro de lecturas recomendadas del programa conocimiento experto El Efecto de la Expectativa de David Robson? Descubre la Eficiencia del Manejo de las Expectativas en tu Salud Mental.Adquiere el Libro: https://amzn.to/3wiecuOAccede a nuestro grupo privado en Facebook: https://www.facebook.com/groups/conocimientoexpertoMonetiza tus Redes Sociales: https://impactoexperto.com/Participa del Reto 60/100 para ser una Mejor Versión: https://conocimientoexperto.com/reto60100Accede a mi sito oficial y desarrolla tu modelo de negocio:https://www.salvadormingo.com/Accede al Programa Principios Experto: https://conocimientoexperto.com/principiosObtén mi libro: https://amzn.to/2KmHMXaMis programas:* Programa Principios Experto: https://conocimientoexperto.com/principios* Libro Conocimiento: https://www.conocimientoexperto.org/unavidaconproposito* Programa Posicionamiento de Expertos en Internet: https://conocimientoexperto.com/programaexperto* Más contenidos gratuitos: https://www.conocimientoexperto.org* Aplicación Móvil Conocimiento Experto: https://www.conocimientoexperto.org/apps/* Programa Conocimiento Experto Elite: https://conocimientoexperto.com/eliteMis redes:* Sígueme En Instagram en: https://www.instagram.com/salvadormingo/* Sígueme en Facebook en: https://www.facebook.com/Conocimientoexperto* Sígueme en Youtube: https://www.youtube.com/SalvadorMingoConocimientoExperto* Sígueme en Twitter en: https://twitter.com/s_mingoParece que la idea de "la mente sobre la materia" tiene un uso en casi cualquier escenario.En el deporte, los entrenadores predican la idea de utilizar la "fortaleza mental" para superar los límites físicos conocidos de nuestro cuerpo.En los negocios, el dicho "si puedes soñarlo, puedes hacerlo" se ha convertido prácticamente en el lema de los empresarios e innovadores de todo el mundo.Y en medicina, incluso el mero hecho de recibir un diagnóstico de enfermedad o salud puede marcar la diferencia en cómo se siente nuestro cuerpo. Piénsalo: ¿Alguna vez te has encontrado leyendo una lista de síntomas de una enfermedad, sólo para empezar a sentir cada uno de esos mismos síntomas poco después? ¿Incluso si no estaban ahí antes? Pero, imaginado o no, el concepto de la mente sobre la materia siempre ha dejado una pregunta persistente: ¿Hasta qué punto puede nuestra mentalidad influir directamente en nuestra realidad? ¿Y hasta qué punto las profecías autocumplidas acaban dando forma a nuestras vidas?David Robson, autor de El efecto de la expectativa, tiene una respuesta: bastante. Y en este análisis descubrirás hasta qué punto tu mente es una poderosa máquina de predicción, dedicada a asegurarse de que tu realidad coincida con tus expectativas internas. Desde el proceso de envejecimiento hasta los efectos de los medicamentos en tu cuerpo, descubrirás el poder de la mente para cambiar tu productividad, tu salud y tu futuro. En este análisis también aprenderás:- Por qué la edad no es más que un número;- Los efectos de los medicamentos placebo en su cuerpo; y- Por qué apuntar a alguien con un hueso de canguro puede ser fatal.Edicion Febrero 2022David Robson es un galardonado escritor científico con cede en el Reino Unido. Licenciado por la Universidad de Cambridge, anteriormente trabajó como redactor en New Scientist y como periodista senior en la BBC. Sus escritos han aparecido en The Guardian, The Atlantic, Men's Health, The Psychologist, The Washington Post y muchas otras publicaciones. Su primer libro, La trampa de la inteligencia, se publicó en 2019 y ha sido traducido a quince idiomas.Enfoque Salud Mental y el Efecto PlaceboSe FirmeSalvador MingoConocimiento Experto#EfectoPlacebo#SaludMental#Expectativas